JPRN-UMIN000002665已完成未知
Comparative study of high-dose ciclesonide and fluticasone on small airway in asthmatics - Comparison of ciclesonide and fluticasone on small airway in asthmatics
Kurume University School of Medicine0 个研究点目标入组 18 人开始时间: 2009年10月25日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 18
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. Inhaled, oral and injective corticosteroids, leukotriene receptor antagonists, inhaled, oral and transdermal long acting beta2 agonists,sodiumchromoglicate, xanthine, immunosuppressive agents, and anti-allergic agents (include anti-IgE antibody) is used 4wks prior to screening. 2. Respiratory infections (within 4wks) 3. Other underlying diseases 4. Any psychological disease 5. Pregnacy
研究者
相似试验
已完成
不适用
Ciclesonide comparison with fluticasone in mild persistent asthmaAsthma.Asthma, unspecifiedIRCT201201028597N1Massih Daneshvari hospital356
进行中（未招募）
不适用
A comparative study of inhaled ciclesonide versus placebo in children with asthma (RAINBOW) - RAINBOWAsthma bronchialMedDRA version: 8.1Level: LLTClassification code 10003555Term: Asthma bronchialEUCTR2006-000803-40-DEycomed GmbH1,050
进行中（未招募）
1 期
A comparative study of inhaled ciclesonide versus placebo in children with asthma (RAINBOW)Estudio comparativo de ciclesonide inhalado frente a placebo en niños con asma - RAINBOWAsthma bronchialAsma bronquial persistenteMedDRA version: 9.0Level: LLTClassification code 10003555EUCTR2006-000803-40-ESALTANA Pharma AG1,080
进行中（未招募）
不适用
A comparative study of inhaled ciclesonide versus placebo in children with asthma (RAINBOW) - RAINBOWEUCTR2006-000803-40-HUALTANA Pharma AG1,050
进行中（未招募）
1 期
Effect of Ciclesonide (320 µg/day) vs. Fluticasone Propionate (375 µg/day) vs. Placebo on Short-term Linear Growth Rate and HPA-axis Function in Prepubertal Children with Mild AsthmaA double-blind, double-dummy, placebo-controlled, randomized, 3 period cross-over studyasthma bronchialeMedDRA version: 5.1Level: lltClassification code 10003553EUCTR2005-001386-34-DKALTANA Pharma AG